Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 1426 AL 1440

GPR55 and PINK1 as emerging therapeutic targets in Glioma: insights into their modulation by phytochemicals and plant extracts

Turizo Smith AD, Martinez Perez JC, Marin Loaiza JC, Arboleda G.

Front Pharmacol. 2026 Jul 24;17:1760169. doi: 10.3389/fphar.2026.1760169. eCollection 2026.

Transcutaneous Auricular Vagus Nerve Stimulation to Improve Daily-Life Gait in Parkinson's Disease: A Case Report

Okada Y, Nishi Y, Hasegawa N, Kataoka H, Nakamura J, Kai T, Ikuno K, Nabeshima S, Doko R, Nishimoto R, Fujita R, Mori Y, Yoshinaga A, Shomoto K.

Brain Neurorehabil. 2026 Jul 15;19(2):e12. doi: 10.12786/bn.2026.19.e12. eCollection 2026 Jul.

Editorial: Nutrients and bioactive compounds: preventing and treating neurodegenerative diseases and disorders

Ortuño-Sahagún D, Carrera-Quintanar L.

Front Nutr. 2026 Jul 24;13:1908638. doi: 10.3389/fnut.2026.1908638. eCollection 2026.

Dysphagia and Dysphonia in Parkinson's Disease: Pathophysiological Mechanisms, Treatment Approaches, and Clinical Implications

Hong ER.

Biomed Hub. 2026 Jun 27;11(1):143-149. doi: 10.1159/000553345. eCollection 2026 Jan-Dec.

An updated patent review of mGlu5 negative allosteric modulators (2018 - present)

Marycleopha M.

Neuroscience. 2026 Oct 15;614:32-42. doi: 10.1016/j.neuroscience.2026.08.002. Epub 2026 Aug 4.

Treatment of Parkinson Disease

Jackson LM, Klassen BT, Ruether E, Savica R.

Mayo Clin Proc. 2026 Aug 4:S0025-6196(26)18661-3. doi: 10.1016/j.mayocp.2026.07.024. Online ahead of print.

Metabolic reprogramming-driven neuroimmunoregulation: Key mechanisms and therapeutic opportunities and challenges in central nervous system disorders

Li N, Wu Y, Feng H, Jian X, Yang Z, Wang X, Li X, Yin Y, Long Y.

Ageing Res Rev. 2026 Oct;121:103291. doi: 10.1016/j.arr.2026.103291. Epub 2026 Aug 8.

The gut-brain-mitophagy axis: Urolithin A as a transcriptional activator of Parkin in Alzheimer's and Parkinson's diseases

Shokr MM, Fawzy MN.

Mol Cell Neurosci. 2026 Aug 8;138:104112. doi: 10.1016/j.mcn.2026.104112. Online ahead of print.

Artificial Intelligence for the Diagnosis and Management of Neurodegenerative Diseases: A Comprehensive Review With an Emphasis on Parkinson's and Alzheimer's Diseases

Pinnelli SP, T SB, Ca J, Pinnelli VB, Harikrishna GV, Mudamanchu VK, Sam KT, Ms D, Bhupathiraju P, Sucharitha AS, Kandi V.

Cureus. 2026 Jul 9;18(7):e112325. doi: 10.7759/cureus.112325. eCollection 2026 Jul.

Dental Caries Experience in Older Adults With Parkinson's Disease: A Systematic Review and Meta-Analysis

Drumond VZ, de Oliveira TA, de Arruda JAA, Pavione RCL, Rocha NB, Mesquita RA, Abreu LG.

Spec Care Dentist. 2026 Jul-Aug;46(4):e70230. doi: 10.1111/scd.70230.

Metabolic Reprogramming of Brain Microglia: Implications for Aging and Aging-Associated Neurodegenerative Diseases

Kang S, Goodridge HS.

Aging Cell. 2026 Aug;25(8):e70660. doi: 10.1111/acel.70660.

Factors associated with selection of total hip arthroplasty versus hemiarthroplasty for femoral neck fracture in older adults: a nationwide analysis of 99,084 cases

Maman D, Steinfield Y, Berkovich Y.

Arch Orthop Trauma Surg. 2026 Aug 10;146(1):288. doi: 10.1007/s00402-026-06459-1.

Fecal microbiota transplantation in Parkinson's disease: a systematic review

Eissazade N, Mosavari H, Eghdami S, Rohani M, Fereshtehnejad SM, Khoeini T.

Neurodegener Dis Manag. 2026 Aug 10:1-14. doi: 10.1080/17582024.2026.2715585. Online ahead of print.

Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors

Birzu C, Bihan K, Wehrung M, Kas A, Valette F, Pouclet-Courtemanche H, Diop Jaffrelot L, Leclercq D, Palassin P, Gaboriau L, Raimbourg J, Autier L, Farina A, Joubert B, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2026 Sep;13(5):e200644. doi: 10.1212/NXI.0000000000200644. Epub 2026 Aug 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias